CSI Market
Sign In | Register

Gri Bio Inc (GRI) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access GRI quarterly Cash Flow →
The quarterly cash flow data below helps track how Gri Bio Inc's liquidity profile has evolved over recent quarters.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
12 Months 		(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Operating Activities
Income-11.96
Depreciation & amortization0.00
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation0.79
Income (Loss) from Equity Method Investments0.00
Fair Value Adjustment of Warrants0.00
Finance Lease Right Of Use Asset Amortization-
Derivative Gain Loss On Derivative Net-
Gain Loss On Derivative Instruments Net Pretax-
Operating Lease Right Of Use Asset Amortization Expense0.05
Increase Decrease In Operating Lease Liability-0.05
Income taxes0.00
Gain (Loss) on Investments0.00
Accounts Receivable0.00
Increase (Decrease) in Accounts Payable0.66
Increase (Decrease) in Accrued Liabilities0.06
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets0.25
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.00
Discontinued operations0.00
Net Cash flow from Operating Activities-10.19
Investing Activities
Capital Expenditures0.00
Sale of Capital Items0.00
Proceeds from Sale and Maturity of Marketable Securities0.00
Payments to Acquire Marketable Securities0.00
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities0.00
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock10.83
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net2.56
Finance Lease Principal Payments-
Proceeds From Issuance Of Common Stock And Warrants Net-
Proceeds From Advances From Employees-
Repayment Of Advances From Employees-
Net Liabilities Assumed In Connection With Reverse Recapitalization-
Payment Of Reverse Recapitalization Costs-
Payments For Redemption Of Redeemable Common Stock-
Payment For Fractional Shares Reverse Stock Split0.00
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities13.39
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-10.19
Total Cash Flow3.20
4 historic quarters locked

Sign in to unlock the full Gri Bio Inc cash flow history.

Sign In Create Free Account

About Gri Bio Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001824293-26-000033

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License